Unlike Noxa and SARM (Figure 3b, arrows) that are consistently reduced in all six HCC cell lines, SAG overexpression did not cause a clear change in the levels of Bcl-2 and Bcl-xL. This evidence concerns the gene BCL2 and hepatocellular carcinoma.